Castleman Disease
Symptoms, Doctors, Treatments, Advances & More

Castleman Disease Overview

Save information for later
Sign Up

Learn About Castleman Disease

What is the definition of Castleman Disease?
Castleman disease is a rare condition that is characterized by an abnormal growth of multiple cells in a single lymph node or multiple lymph nodes (depending on the type of disease), causing them to enlarge. There are two main types of Castleman disease: 1) Unicentric Castleman disease (UCD) affects a single lymph node, usually in the chest or abdomen and is the most common form of the disease. 2) Multicentric Castleman disease (MCD) affects multiple lymph nodes and has two subtypes which are commonly associated with having been infected with the human immunodeficiency virus (HIV): 2a) Human herpes virus type 8 (HHV-8-associated MCD) 2b) Human herpes virus type-8 (HHV-negative or idiopathic MCD ), which is also known as Kaposi sarcoma-associated herpesvirus.
What are the alternative names for Castleman Disease?
There are several alternative names for Castleman disease, including angiofollicular lymph node hyperplasia, giant lymph node hyperplasia, and lymphoid hamartoma. Castleman disease may also be abbreviated to CD.
What are the different types of Castleman Disease?

Common conditions include: Multicentric Castleman Disease (MCD), Unicentric Castleman Disease (UCD)

What are the causes of Castleman Disease?
While the exact cause is unknown, unicentric Castleman disease is currently believed to be caused by genetic mutations and inflammation. Multicentric Castleman disease can be caused by having been infected with human herpesvirus 8 (HHV-8) and human immunodeficiency virus (HIV). However, when the human herpesvirus 8 is not present, then the cause in unknown, in which case the disease is referred to as being idiopathic (of unknown cause) multicentric Castleman disease.
What are the symptoms of Castleman Disease?
Patients with unicentric Castleman disease may not experience any symptoms, and the disease may only be detected when a single enlarged lymph node is discovered in the neck, chest, or abdomen during an examination. Some patients with unicentric Castleman disease may have symptoms similar to those in multicentric Castleman disease, such as fatigue, unexplained weight loss, nausea, skin rash, fever, night sweats, anemia, an enlarged liver and spleen (hepatosplenomegaly), and high levels of immune factors in the blood (hypergammaglobulinemia). Symptoms of multicentric Castleman disease include multiple areas of enlarged lymph nodes, unexplained weight loss, fatigue, loss of appetite, shortness of breath, nausea and vomiting, skin rash, fever, night sweats, anemia, an enlarged liver and spleen (hepatosplenomegaly), peripheral neuropathy (pain and tingling in arms, hands, legs, and feet), and high levels of immune factors in the blood (hypergammaglobulinemia).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Castleman Disease?
Treatment for Castleman disease depends on the type and severity. Treatment for unicentric Castleman disease involves surgery to remove the affected lymph node, which can cure the disease. If the lymph node is in an area that cannot be operated on (unresectable), then medication and ionizing radiation therapy (radiotherapy) may be used to destroy the affected lymph node. Treatment for multicentric Castleman disease depends on the severity and type and whether the patient is infected with the human immunodeficiency virus (HIV), human herpesvirus 8 (HHV-8), or both. A treatment plan may include medications to stop the cell overgrowth (immunotherapy; siltuximab , rituximab , IL-6 , sirolimus, or anakinra); chemotherapy; corticosteroids, such as prednisone, to control inflammation; antiviral drugs to block human immunodeficiency virus (HIV) or human herpesvirus 8 (HHV-8) or both; and bone marrow transplant (for severe disease).
Who are the top Castleman Disease Local Doctors?
Elite in Castleman Disease
Dr. Sudipto Mukherjee
Hematology | Oncology
Elite in Castleman Disease
Dr. Sudipto Mukherjee
Hematology | Oncology
Referral may be required

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
866-223-8100
Languages Spoken:
English, Bengali, Hindi
See accepted insurances
Offers Telehealth

Sudipto Mukherjee is a Hematologist and an Oncologist practicing medicine in Cleveland, Ohio. Dr. Mukherjee is rated as an Elite provider by MediFind in the treatment of Castleman Disease. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Multicentric Castleman Disease (MCD), Castleman Disease, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Mukherjee is board certified in American Board Of Internal Medicine, 2019.

Elite in Castleman Disease
Dr. Peter Voorhees
Hematology | Oncology
Elite in Castleman Disease
Dr. Peter Voorhees
Hematology | Oncology
Referral required

Atrium Health Levine Cancer Institute (Hematology)

1021 Morehead Medical Drive, Building 2, Suite 60201, 
Charlotte, NC 
980-442-4363
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Voorhees is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Voorhees is rated as an Elite provider by MediFind in the treatment of Castleman Disease. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Voorhees is board certified in American Board Of Internal Medicine, Hematology. Dr. Voorhees is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Castleman Disease
Elite in Castleman Disease
Referral may be required

Clinical Cancer Center - Froedtert Hospital

8800 W. Doyne Ave., 
Milwaukee, WI 
414-805-0505
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dr. Kurzrock is a world-renowned leader in precision oncology and rare cancers research. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair for the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading eight life-changing drugs to FDA approval. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work. Dr. Kurzrock is rated as an Elite provider by MediFind in the treatment of Castleman Disease. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Tissue Biopsy. Dr. Kurzrock is board certified in Internal Medicine and Medical Oncology. Dr. Kurzrock is currently accepting new patients.

View All Doctors
What are the support groups for Castleman Disease?
There are several online, local, national, and international support groups for Castleman disease, including the following: Castleman’s Connect - https://www.castlemansconnect.com/connect-with-castleman-community/ Castleman Disease Collaborative Network - https://cdcn.org/patients-loved-ones/find-support/ Rare Connect: Castleman’s Disease - https://www.rareconnect.org/en/community/castleman-disease/members
What is the outlook (prognosis) for Castleman Disease?
The outcomes (prognosis) for unicentric Castleman are good as the disease can generally be cured with surgical removal of the affected lymph node. The outcomes (prognosis) for multicentric Castleman disease are varied as, in some patients, the disease can be characterized by periods of stable disease (not progressing) that can last for months or years. Other patients with multicentric Castleman disease may experience episodes of severe symptoms that may improve without treatment or respond to treatment, only to recur. Patients who are positive for the human immunodeficiency virus (HIV-positive) generally have poor outcomes (prognosis), as they have an increased risk of developing a severe form of multicentric Castleman disease that can progress rapidly, causing death within a period of weeks.
What are the possible complications of Castleman Disease?
Patients with unicentric Castleman usually do not experience any complications and can be cured after surgical removal of the affected lymph node. Complications for patients with multicentric Castleman disease may include life-threatening infections or organ failure. Patients with multicentric Castleman disease and human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) may experience severe, rapidly progressing disease and death. In rare instances, an affected lymph node in a patient with multicentric Castleman disease may form close to a blood vessel, causing an obstruction or aneurysm (ballooning of a blood vessel) requiring surgery. Having either type of Castleman disease can increase the risk of developing lymphoma (cancer of the lymph nodes).
When should I contact a medical professional for Castleman Disease?
If you discover an enlarged lymph node on the side of the neck, collarbone, under the arm, or in the groin area, or if you experience fatigue, unexplained weight loss, fever, or a persistent feeling of fullness in the chest or abdomen, make an appointment with your doctor as soon as possible.
How do I prevent Castleman Disease?
Since patients with human immunodeficiency virus are at an increased risk of developing human herpesvirus 8 (HHV-8) multicentric Castleman disease (HHV-8-associated MCD), avoiding infection with human immunodeficiency virus by practicing safe sex, limiting sex partners, avoiding injected street drug use and the use of dirty needles, and taking the pre-exposure prophylaxis pill (PrEP) can help to prevent HIV infection and reduce the risk of developing multicentric Castleman disease.
What are the latest Castleman Disease Clinical Trials?
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
Enrollment Status: Recruiting
Publish Date: June 18, 2026

Summary: BACKGROUND: * A number of important scientific advances can be made through the study of blood, bone marrow, tumor, or other tissue samples from patients with HIV infection, infection with Kaposi s sarcoma associated herpesvirus (KSHV), infection with other oncogenic viruses, or cancer. * This protocol provides a mechanism to affect a variety of such studies. OBJECTIVES: -Acquisition of serum, cir...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Enrollment Status: Recruiting
Publish Date: June 15, 2026

Background: A person s genome is the collection of all their genes. A gene instructs individual cells to make proteins. Proteins are involved in all of our body s chemical processes. Genome sequencing allows researchers to find variations in genes. Some of these are normal and are not known to cause disease. Some variants are known to cause or affect diseases like cancer. Researchers want to study genetic var...

View All Clinical Trials
What are some Advocacy Organizations?
castleman-disease

The Castleman Disease Collaborative Network (CDCN) is a global initiative dedicated to accelerating research and treatment for Castleman disease and revolutionizing biomedical research.